| Genomic landscape of cutaneous T cell lymphoma J Choi, G Goh, T Walradt, BS Hong, CG Bunick, K Chen, RD Bjornson, ... Nature genetics 47 (9), 1011-1019, 2015 | 460 | 2015 |
| Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung … YK Chae, A Arya, W Iams, MR Cruz, S Chandra, J Choi, F Giles Journal for immunotherapy of cancer 6, 1-27, 2018 | 453 | 2018 |
| Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy G Goh, T Walradt, V Markarov, A Blom, N Riaz, R Doumani, K Stafstrom, ... Oncotarget 7 (3), 3403, 2015 | 407 | 2015 |
| T lymphocyte–endothelial cell interactions J Choi, DR Enis, KP Koh, SL Shiao, JS Pober Annu. Rev. Immunol. 22 (1), 683-709, 2004 | 274 | 2004 |
| IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression X Zhang, A Rao, P Sette, C Deibert, A Pomerantz, WJ Kim, G Kohanbash, ... Neuro-oncology 18 (10), 1402-1412, 2016 | 161 | 2016 |
| Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p. Q575E) J Park, J Yang, AT Wenzel, A Ramachandran, WJ Lee, JC Daniels, J Kim, ... Blood, The Journal of the American Society of Hematology 130 (12), 1430-1440, 2017 | 160 | 2017 |
| The coincidence between increasing age, immunosuppression, and the incidence of patients with glioblastoma E Ladomersky, DM Scholtens, M Kocherginsky, EA Hibler, ET Bartom, ... Frontiers in pharmacology 10, 200, 2019 | 138 | 2019 |
| Are there multiple cells of origin of Merkel cell carcinoma? JC Sunshine, NS Jahchan, J Sage, J Choi Oncogene 37 (11), 1409-1416, 2018 | 132 | 2018 |
| Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma M Bi, S Zhao, JW Said, MJ Merino, AJ Adeniran, Z Xie, CB Nawaf, J Choi, ... Proceedings of the National Academy of Sciences 113 (8), 2170-2175, 2016 | 128 | 2016 |
| Telomere replication stress induced by POT1 inactivation accelerates tumorigenesis AM Pinzaru, RA Hom, A Beal, AF Phillips, E Ni, T Cardozo, N Nair, J Choi, ... Cell reports 15 (10), 2170-2184, 2016 | 123 | 2016 |
| Progression of cutaneous T-cell lymphoma after dupilumab: case review of 7 patients ML Espinosa, MT Nguyen, AS Aguirre, ME Martinez-Escala, J Kim, ... Journal of the American Academy of Dermatology 83 (1), 197-199, 2020 | 113 | 2020 |
| Classification of human chronic inflammatory skin disease based on single-cell immune profiling Y Liu, H Wang, M Taylor, C Cook, A Martínez-Berdeja, JP North, ... Science immunology 7 (70), eabl9165, 2022 | 101 | 2022 |
| Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas J Daniels, PG Doukas, MEM Escala, KG Ringbloom, DJH Shih, J Yang, ... Nature communications 11 (1), 1806, 2020 | 93 | 2020 |
| Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis SD Allen, YG Liu, T Kim, S Bobbala, S Yi, X Zhang, J Choi, EA Scott Biomaterials science 7 (2), 657-668, 2019 | 87 | 2019 |
| Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity J Park, J Daniels, T Wartewig, KG Ringbloom, ME Martinez-Escala, ... Blood, The Journal of the American Society of Hematology 138 (14), 1225-1236, 2021 | 80 | 2021 |
| Inhibition of phosphatidylinositol 3-kinase sensitizes vascular endothelial cells to cytokine-initiated cathepsin-dependent apoptosis LA Madge, JH Li, J Choi, JS Pober Journal of Biological Chemistry 278 (23), 21295-21306, 2003 | 78 | 2003 |
| Merkel cell carcinoma patients presenting without a primary lesion have elevated markers of immunity, higher tumor mutation burden, and improved survival N Vandeven, CW Lewis, V Makarov, N Riaz, KG Paulson, D Hippe, ... Clinical Cancer Research 24 (4), 963-971, 2018 | 77 | 2018 |
| Treatment of hypereosinophilic syndrome with cutaneous involvement with the JAK inhibitors tofacitinib and ruxolitinib B King, AI Lee, J Choi Journal of Investigative Dermatology 137 (4), 951-954, 2017 | 73 | 2017 |
| Genetics of cutaneous T cell lymphoma: from bench to bedside WE Damsky, J Choi Current treatment options in oncology 17, 1-14, 2016 | 70 | 2016 |
| Genomic analyses identify recurrent alterations in immune evasion genes in diffuse large B-cell lymphoma, leg type XA Zhou, A Louissaint Jr, A Wenzel, J Yang, ME Martinez-Escala, AP Moy, ... Journal of Investigative Dermatology 138 (11), 2365-2376, 2018 | 69 | 2018 |
